跳至主要内容
临床试验/NCT01462422
NCT01462422已完成不适用

Two Community Strategies Comparing Use of Misoprostol for Secondary Prevention to Primary Prevention for Postpartum Hemorrhage: A Randomized Cluster Non-Inferiority Study in Bijapur District, Karnataka, India

Gynuity Health Projects1 个研究点 分布在 1 个国家目标入组 3,032 人开始时间: 2011年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
3,032
试验地点
1
主要终点
Proportion of women with post-delivery hemoglobin ≤ 7.8 gm/dL

研究概览

简要总结

This study compares two community-level strategies: selective administration of 800 mcg sublingual misoprostol to women at 350 mL blood loss for secondary prevention of postpartum hemorrhage (PPH) with universal use of 600 mcg oral misoprostol at the time of delivery for primary prevention of PPH. The study hypothesizes that at community-level births, secondary prevention for women is non-inferior (based on clinical parameters) to universal prophylaxis provided to women for primary prevention of PPH. This cluster-design non-inferiority trial has the potential to inform service delivery programs on clinical outcomes, program feasibility, cost and acceptability of two different community models of PPH care using misoprostol.

详细描述

Rationale for Research: There is an absence of concrete data on the programmatic and cost-effectiveness of different service delivery models for prevention and treatment of postpartum hemorrhage with misoprostol, prompting a discussion of whether resources are best spent on misoprostol for primary prevention at lower levels (with treatment carried out at higher levels via referral) or whether immediate proactive treatment strategies should be considered. As the training and policy implications of universal prevention versus selective treatment approaches vary, simple and effective service delivery models are urgently needed to help governments and organizations decide how to best focus their limited resources. This study proposes to study the efficacy of a hybrid strategy (i.e., secondary prevention) that combines elements of prevention and treatment. Results of this study could provide a new model of care that will medicate fewer women, save costs and address the clinical conundrum of guessing at the safety of administering a prevention dose of misoprostol followed quickly by a larger treatment dose.

Study design: This randomized cluster trial will recruit women with deliveries attended by auxiliary nurse midwives (ANMs) that occur at homes or at health sub-centers. ANMs will be randomized to administer the intervention as described in the primary or secondary prevention arm.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
15 Years 至 45 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • delivering at home or sub-center with an auxilliary nurse midwife (ANM)
  • able and willing to provide informed consent
  • meeting Ministry of Health Guidelines for home or sub-center delivery

排除标准

  • high-risk pregnancy

研究组 & 干预措施

Primary prevention

Other

干预措施: Misoprostol (Drug)

Secondary Prevention

Other

干预措施: Misoprostol (Drug)

结局指标

主要结局

Proportion of women with post-delivery hemoglobin ≤ 7.8 gm/dL

时间窗: 72 hours (plus or minus 8 hours) after delivery

A 20% rate of post delivery Hb ≤7.8 gm/dL in the study arm with women receiving selective administration of 800 mcg sublingual misoprostol is non-inferior to a 13% rate of post delivery Hb ≤ 7.8 gm/dL in the study arm with women receiving universal 600 mcg oral misoprostol prophylaxis.

次要结局

  • Rate of transfer to referral facilities for PPH(within 72 hours (plus or minus 8 hours) after delivery)
  • Rate of PPH(within 1 hour after delivery)
  • Rate of severe PPH(within 1 hour after delivery)
  • Rate of adverse events(Within 72 hours (plus or minus 8 hours) after delivery)
  • Mean blood loss(1 hour after delivery)
  • Rate of additional interventions needed to control bleeding(within 72 hours (plus or minus 8 hours) after delivery)
  • Cost-effectiveness(72 hours (plus or minus 8 hours) after delivery)
  • Proportion of women reporting known side effects of misoprostol(1 hour after delivery)
  • Acceptability of intervention to women(72 hours (plus or minus 8 hours) after delivery)

研究者

发起方
Gynuity Health Projects
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验